(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 15.99% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.45%.
Twist Bioscience's revenue in 2024 is $262,364,000.On average, 4 Wall Street analysts forecast TWST's revenue for 2024 to be $16,869,969,005, with the lowest TWST revenue forecast at $16,813,480,798, and the highest TWST revenue forecast at $16,923,913,220. On average, 4 Wall Street analysts forecast TWST's revenue for 2025 to be $20,412,363,577, with the lowest TWST revenue forecast at $19,985,377,485, and the highest TWST revenue forecast at $21,138,268,843.
In 2026, TWST is forecast to generate $23,940,130,189 in revenue, with the lowest revenue forecast at $23,190,808,624 and the highest revenue forecast at $24,689,451,754.